Cellular & Viral Immunology Lab (CVI) (with virus-Biosafety BSL2+ facility)
Scientific Area: Medical and Health Sciences.
EXPR: Immunology-Other clinical medicine subjects-Infectious diseases-Technologies involving the manipulation of cells, tissues, organs or the whole organism (assisted reproduction)-Molecular Virology, Cellular biology, Molecular Biology.
Name of the service: Cellular & Viral Immunology Lab (CVI) (with virus-Biosafety BSL2+ facility).
Main responsible: AgustĂn Valenzuela-Fernández & Rodrigo Trujillo-González / PIs and Professors at ULL.
Category of the service: Research Group and with the BSL2+ facility & accredited health unit (potential virus-technological service).
Target group: Biotech, Biomed, hospitals.
Scientific refence:Â
Virologist and Immunologist, Full Professor of Medicine, working on deciphering the mechanisms underlying the infection and pathogenesis, or its control of RNA+ virus, such as HIV-1, Zika and SARS-CoV-2. Recently, working in virosurveillance for SARS-CoV-2 and Monkeypox outbreaks. Doctoral Thesis in Biochemistry, and Molecular Biology on HIV/AIDS at the UB (CIRIT-fellowship, 1993-1997). In 1996, predoctoral fellowship (CIRIT), Department AIDS/Retrovirus Pasteur Institute (Paris, France) directed by Luc Montagnier (Nobel Prize in Medicine 2008). Postdoctoral stage (1998-2002) in the Viral Immunology Unit of the same Pasteur I. (Dr. F. Arenzana-Seisdedos & J-L. Virelizier), studying the first co-receptor for HIV-1 (CXCR4 & SDF-1) (Marie Curie CE Contract (1998-2000), acquiring the status of -Investigator Hired Pasteur- extended with ANRS contract (Feb.2003)). I collaborated with Hybrigenics SA. Next, I obtained a “RamĂłn y Cajal” Contract (2003-2007) in Medicine (ranked 3rd national) in the Faculty of Medicine (UAM, Madrid)”. In 2005, I created the “Cellular & Viral Immunology” Lab. In 2006, I started in Fac. Medicine at ULL. In 2007, I received the highest rating-entire scientific career (I3 Program). I have been IP of 25 projects, participating in > 41 competitive projects. IP Biosafety Lab BSL2+/-ULL (UNLL10-3E-783; Certificated Health Unit #U.76 (ref. #7261; order #2728/2017)). 71 JCR publications (>4,100 cites): 51 Q1 & 3 D1 JCR-indexes articles (Hindex 30, i10 45).
Offer description:
Development and use of safe viral-cellular models for the study of emerging viruses, from the mechanisms of infection to those of neutralization by drugs, antibodies (from vaccines or from convalescent patients) and cellular restriction factors, as well as in the characterization of new viral and cellular therapeutic targets.
Contact Form
“This service is part of a much larger catalogue that we have at your disposal. If you would like to make an enquiry about this particular service, or any related service, please fill in the contact form on our website“.